(2E)-3-(3-bromophenyl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

1-Phenyl-1-[4-(propan-2-yl)pyridin-2-yl]ethan-1-ol, 1g

(R)-1-Phenylethanol, 95.0%, 1g

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid, 95.0%, 25g

ethyl 2-(3,4-dichlorophenyl)ethanecarboximidate hydrochloride, 95.0%, 2g

(S)-(-)-DBD-Pro-COCl [=(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>90.0%(HPLC)100mg

Chrysoidin R (CI 11320), pure, 10 g, glass packaging

2,5-Dichloro-4-aminophenol, 96.0%, 100mg

(E)-(3-(3-Ethoxy-3-oxoprop-1-en-1-yl)phenyl)boronic acid, 95.0%, 5g

METHYL 6-ACETYLQUINOLINE-3-CARBOXYLATE, 95.0%, 250mg

5-bromo-2-isopropoxybenzaldehyde, 95.0%, 250mg

4-Bromoisophthalonitrile, 95.0%, 1g

2,2,2-Trichloro-1-(1-ethyl-4-nitro-1H-pyrrol-2-yl)-ethanone, 95.0%, 1g